Showing 76 to 90 of 463 results
Radiographers renewals - window closing soon
The deadline for radiographers to complete their registration renewal is fast approaching
Biomedical scientists renewals - window closing soon
The deadline for biomedical scientists to complete their registration renewal is fast approaching
Occupational therapists renewals - window closing soon
The deadline for occupational therapists to complete their registration renewal is fast approaching
August bank holiday 2023 service availability
The HCPC offices will be closed on Monday 28 August for the summer bank holiday weekend
HCPC responds to COVID-19 Vaccines Delivery Plan
The UK Government published its COVID-19 Vaccines Delivery Plan on Monday 11th January.
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
Key findings from the Year in Registration Survey 2023
Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice.
HCPC statement on guidance on health and character and suicidal ideation
Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.
Update on the Indicative Sanctions Policy review
In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
The two criteria for choosing CPD
Continuing professional development (CPD) should improve your work and have a positive impact for your service users